Nanoviricides, Inc.
- Last sale
- Nov 6, 2026 · +0.38%
- Market cap
- $33.73M
- 25.55M shares
- Filings
- 557
Q1 2027
Q1 2027N/M FY26 yoy
Q1 2027N/M FY26 yoy
FY 2026derivedN/M FY26 yoy
Q1 2027N/M FY26 yoy
Q1 2027+79.3% FY26 yoy
- $33.73M
- —
- —
- 5.3×
- —
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 6, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2026 | 2026-06-30 | $0 | reported | |
| FY 2025 | 2025-06-30 | $0 | reported | |
| FY 2024 | 2024-06-30 | $0 | reported | |
| FY 2023 | 2023-06-30 | $0 | reported |
Pharmaceutical preparations
Nanoviricides, Inc. is the 357th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
VERUVeru Inc.Fiscal 2025 figures———$36.1MTELOTelomir Pharmaceuticals, Inc.———$36.1MANVSAnnovis Bio, Inc.$0.0——$35.7MANEBAnebulo Pharmaceuticals, Inc.Fiscal 2025 figures———$35.5MOSTXOS Therapies Inc———$34.6MAARDAardvark Therapeutics, Inc.$0.0——$33.9M
NNVCNanoviricides, Inc. (this company)$0.0——$33.7M
SCYXScynexis Inc$20.6M449.9%41.8%$32.9MPMNProMIS Neurosciences Inc.———$31.6MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Nanoviricides, Inc. · CIK 1379006 · Engraved from SEC EDGAR